论文信息 - Serum level of sFas in patients with Wegener’s granulomatosis - 字舞流文

Serum level of sFas in patients with Wegener’s granulomatosis

P. Kotyla | E. Kucharz | A. Kotulska | M. Kopeć | R. Pieczyrak | B. Krupnik

[1] Masaharu Yoshida. [Wegener's granulomatosis: Pathogenesis, pathophysiology, and therapy]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[2] F. Kiechle,et al. Apoptosis: biochemical aspects and clinical implications. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[3] Hanns-Martin Lorenz,et al. Differential Role for IL‐2 and IL‐15 in the Inhibition of Apoptosis in Short Term Activated Human Lymphocytes , 1997, Scandinavian journal of immunology.

[4] J. Levine,et al. Antineutrophil Cytoplasmic Autoantibodies Interact with Primary Granule Constituents on the Surface of Apoptotic Neutrophils in the Absence of Neutrophil Priming , 1996, The Journal of experimental medicine.

[5] Thomas G. Benedek,et al. Dubois' Lupus Erythematosus , 1987 .

[6] Y. Goltsev,et al. Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.